David B. Weiner - 26 Feb 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Director
Signature: /s/ David B. Weiner
Issuer symbol: INO
Transactions as of: 26 Feb 2023
Net transactions value: -$14,935
Form type: 4
Filing time: 28 Feb 2023, 16:40:24 UTC
Previous filing: 11 Aug 2022
Next filing: 13 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+11,667	+1.3%		904,292	26 Feb 2023	Direct	F1
transaction	INO	Common Stock	Options Exercise		+11,667	+1.3%		915,959	26 Feb 2023	Direct	F2
transaction	INO	Common Stock	Sale	$14,935	-11,668	-1.3%	$1.28	904,291	27 Feb 2023	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-11,667	-50%	$0.000000	11,666	26 Feb 2023	Common Stock	11,667		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-11,667	-33%	$0.000000	23,333	26 Feb 2023	Common Stock	11,667		Direct	F2
transaction	INO	Common Stock Option	Award	$0	+60,000		$0.000000	60,000	27 Feb 2023	Common Stock	60,000	$1.24	Direct	F4
transaction	INO	Restricted Stock Unit	Award	$0	+35,000		$0.000000	35,000	27 Feb 2023	Common Stock	35,000		Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F3	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022.
F4	The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026.
F5	Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.